- Larimar Therapeutics (LRMR -3.4%), Avadel Pharmaceuticals (AVDL +1.7%) and Applied Therapeutics (APLT +2.5%) have been selected to be included in the NASDAQ Biotechnology Index.
- The addition to the index will become effective prior to market open on Monday, December 21.
- In comparison to the gain in the iShares NASDAQ Biotechnology Index Fund (IBB -0.8%) past 1-year performance, which tracks the index, LRMR has garnered higher returns, while AVDL and APLT have under performed during the same period.
- In comparison to the gain in the iShares NASDAQ Biotechnology Index Fund (IBB -0.8%) past 1-year performance, which tracks the index, LRMR has garnered higher returns, while AVDL and APLT have under performed during the same period.
- https://seekingalpha.com/news/3644515-larimar-avadel-applied-therapeutics-will-added-to-nasdaq-biotechnology-index
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.